Wednesday, June 10, 2026
🇺🇸 FDA

Drug profile · INN

administered

administered is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 19
Pipeline programs 68
News articles 0
Drug details — administered
Class
—
Route
—
Patents
19
Programs
68
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

administered is an FDA-listed pharmaceutical active ingredient.

Key facts

INN administered

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. CLI-06657AA1-03 Phase 3 · Chiesi Farmaceutici S.p.A · Fabry disease (α-galactosidase A deficiency)
  2. CT-P13 3.11 Phase 3 · Celltrion Healthcare Australia · Rheumatoid arthritis
  3. Directly administered antiretroviral therapy (DAART) Phase 3 · BRIGHT MINDS BIOSCIENCES · HIV Infections
  4. LUM-201-10 Phase 3 · Anaxis Pharma · Growth Hormone Deficiency (GHD)
  5. TAK-079-3001 Phase 3 · Takeda · IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also kn
  6. VP-VEC-162-3108 Phase 3 · Anaxis Pharma · Insomnia Disorder
  7. VP-VEC-162-3502 Phase 3 · Anaxis Pharma · Delayed Sleep-Wake Phase Disorder (DSWPD)
  8. VP-VHX-896-3201 Phase 3 · Vanda Pharmaceuticals Netherlands · Major Depressive Disorder

Related patents

Browse patents

  1. US 11850259

    Methods of treating viral infections affecting the respiratory tract using topically administered lithium agents

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11207429

    Method and compositions for orally administered contrast agents for MR imaging

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10478505

    Edible oils to enhance delivery of orally administered steroids

    Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. PT 2481410

    NITROCATECHOL DERIVATES AS COMT INHIBITORS ADMINISTERED WITH A SPECIFIC DOSAGE REGIME

    Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 2014356438

    PERIPHERALLY ADMINISTERED VISCOUS FORMULATIONS

    Expires Wed Nov 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8697048

    Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8404635

    Orally administered peptides synergize statin activity

    Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7820784

    Orally administered peptides synergize statin activity

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7807640

    Orally administered peptides synergize statin activity

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7531514

    Orally administered peptides synergize statin activity

    Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7199102

    Orally administered peptides synergize statin activity

    Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7166578

    Orally administered peptides synergize statin activity

    Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7148197

    Orally administered small peptides synergize statin activity

    Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7144862

    Orally administered peptides to ameliorate atherosclerosis

    Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 6933279

    Orally administered peptides to ameliorate atherosclerosis

    Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6752996

    Use of parapox PP30 protein to modify immune responses to administered antigens

    Expires Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6723329

    Use of parapox B2L protein to modify immune responses to administered antigens

    Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6664230

    Orally administered peptides to ameliorate atherosclerosis

    Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6010691

    Methods for enhancing permeation of a topically administered physiologically active substance

    Expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is administered?

administered is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.